Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Burroughs Wellcome Co.

Division of GlaxoSmithKline PLC

Latest From Burroughs Wellcome Co.

End Of The 'March-In' Pricing Petitions?

KEI vows to continue battle over Bayh-Doyle restrictions after US Commerce Department suggests it may issue regulations to exclude pricing as a basis for requiring companies to license their patents.

Intellectual Property NGO Action

'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs

Implementer of many drug review changes will leave in January after nearly 32 years of public service.

Drug Review FDA

Wellcome Trust Launches £200 million “Evergreen” Investment Fund

Britain’s charitable foundation The Wellcome Trust has formally launched a £200 million ($325 million) fund that will invest in both early and growth-stage companies, taking a long-term view and focused initially on opportunities in the UK, Europe and on the U.S East Coast.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • GlaxoSmithKline PLC
  • Senior Management
  • Philip Tracy, Pres. & CEO
    Donald H Namm, VP, Planning and Business Development
    Timothy G Rothwell, VP, Marketing & Sales
    David Barry, PhD, Director, Research & Development
  • Contact Info
  • Burroughs Wellcome Co.
    Phone: (888) 825-5249
    5 Moore Drive
    P.O. Box 13398
    Research Triangle Park, NC 27709